The 10 latest articles on STIs & HIV Prevention come from 7 sources, published between Oct 1 and Nov 13. Most come from BIOENGINEER.ORG (3) and who.int (2).
People in these stories: Ophelia Keating (2)
Organizations: Gilead Sciences (2), CDC (2), UNAIDS (2)
Places: United States (2), U.S. (2), California (2), US (2), County (2)
Home / Research Centers, Institutes, and Labs / Center for Biostatistics in AIDS Research (CBAR) Department of Biostatistics CBAR’s mission is to foster statistical science in clinical trials and other research studies in infectious diseases particularly HIV. CBAR pursues this mission by…
Posted by Mitch Edgeman on Nov 13th, 2026 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Gilead Sciences (NASDAQ:GILD) is preparing for a potential launch of its multiple myeloma cell therapy anito-cel, with plans to build on…
A sign advertises free HIV testing in the Oak Lawn neighborhood of Dallas, Tuesday, Nov. 22, 2022. The federal government has cut $29.2 million from Texas health organizations that test thousands of people for HIV directly in their communities, the latest in a…
Each year on 17 May, the world marks the International Day Against Homophobia, Biphobia, and Transphobia (IDAHOBIT) – a call to action to eliminate discrimination against lesbian, gay, bisexual, transgender and queer (LGBTQ+) people in all aspects of life, including health care.
PAHO Barbados Islands have eliminated mother-to-child transmission of HIV. This milestone reflects the territory's strong commitment to protecting the health of women, children, and families. © Credits Barbados eliminates mother-to-child transmission of HIV 30 October 2026 News release Geneva / Washington, D.C. / Bridgetown…
Advertisement News|Videos|November 12, 2026 The Prospective Emergence of XDR Shigella Beyond High-Risk Groups Author(s)John Parkinson, Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP) Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it…
News provided by ViroPharma Incorporated Jun 27, 2013, 08:00 ET EXTON, Pa., June 27, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced updated data from the two ongoing, Phase 2 dose ranging studies investigating maribavir for both first line treatment of cytomegalovirus (CMV) viremia and treatment of…
Testing, PrEP/PEP, treatment, and reducing stigma in sexual health care.
An article joins this feed when it matches these terms. Each one is also a search of its own.